![]()
|
Report Date : |
26.09.2008 |
IDENTIFICATION
DETAILS
|
Name : |
HIPOLABOR FARMACEUTICA LTDA. |
|
|
|
|
Registered Office : |
Rodovia BR 262, S/N°, KM 12,3 - Bairro Borges 34735-000 - Sabará/MG |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2007 |
|
|
|
|
Date of Incorporation : |
02.07.1984 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 1.000.000,00. |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
HIPOLABOR
FARMACEUTICA LTDA.
|
MAIN ADDRESS: |
RODOVIA BR 262, S/N°, KM 12,3 - BAIRRO BORGES |
|
ZIP CODE/CITY: |
34735-000 - SABARÁ/MG |
|
|
|
|
PHONE: |
31 3408-1800 |
|
FAX: |
31 3408-1800 |
|
E-MAIL: |
robertoloures@hipolabor.com.br |
|
WEB SITE: |
www.hipolabor.com.br |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RODOVIA BR 262,4600 - AARÃO REIS |
|
ZIP CODE/CITY: |
31950-640 BELO HORIZONTE/MG |
|
PHONE: |
31 3408-1800 |
|
FAX: |
31 3408-1802 |
|
CNPJ: |
19.570.720/0003-82 |
|
STATE REGISTER: |
062.425899-01-58 |
|
MAIN ACTIVITIES: |
|
MANUFACTURE OF PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
02/07/1984 |
|
REGISTER DATE: |
02/07/1984 |
|
BALANCE SHEET FILING DATE: |
12/31 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
19.570.720/0001-10 |
|
STATE REGISTER: |
567425.899.00-73 |
|
|
|
|
SHARE CAPITAL: |
R$ 4.404.020,00 |
|
LAST REGISTER OF CAPITAL: |
26/01/2004 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
ILDEU DE OLIVEIRA N. DE MAGALHÃES |
SUPERVISING DIRECTOR |
|
THE DIRECTOR IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
ILDEU DE OLIVEIRA MAGALHÃES |
97% |
|
VIRGÍNIA ARANTES NEVES DE MAGALHÃES |
1% |
|
GUSTAVO NEVES DE MAGALHÃES |
1% |
|
ANDRÉ NEVES MAGALHÃES |
1% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
|
|
NOT AVAILABLE. |
|
|
THE SUBJECT'S
ACTIVITIES WERE STARTED ON JULY, 02 1984 BY THE COMPANY KANDA INDUSTRIA
FARMACÊUTICA LTDA. ON APRIL, 30 1999
THAT COMPANY WAS TAKEN OVER BY THE SUBJECT WHICH THEN TOOK OVER ALL THE
ACTIVITIES WHICH WERE FORMERLY CARRIED OUT BY THE KANDA. SINCE THAT
TAKEOVER THEREFORE, ALL THE ACTIVITIES ARE CARRIED OUT BY THE SUBJECT
COMPANY, OPERATING WITH THE REGISTERED NAME HIPOLABOR FARMACÊUTICA LTDA. PARTNERS: ILDEU DE
OLVEIFRA MAGALHÃES: BRAZILIAN, MARRIED, INDUSTRIAL, RESIDENTIAL ADDRESS AT
RUA DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE, MG, HOLDER OF
DOCUMENTS RG M- 570.996 AND CPF 138.361.376/15. VIRGINIA ARANTES
NEVES DE MAGALHÃES IS BRAZILIAN, BUSINESS ADMINISTRATOR, RESIDENTIAL ADDRESS
AT RUA DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE, MG, HOLDER OF
DOCUMENTS RG M-995.424 AND CPF 315221496-00. GUSTAVO NEVES DE
MAGALHÃES: BRAZILIAN, SINGLE, RESIDENTIAL ADDRESS AT RUA DESEMBARGADOR FÁBIO
MALDONADO Nº174, BELO HORIZONTE/MG, HOLDER OF DOCUMENTS, RG
MG-10.742.772SSP/MG E CPF 053.214.066-42; ANDRÉ NEVES
MAGALHÃES: BRAZILIAN, SINGLE, EMPRESÁRIO, RESIDENTIAL ADDRESS AT RUA
DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE/MG, HOLDER OF DOCUMENTS,
RG MG-11.531.172SSP/MG E CPF 059.035.236-92. FURTHER DETAILS
ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
GENERAL BALANCE SHEETS AS OF 31/12/2007,
31/12/2006 AND 31/12/2005. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2007 |
31/12/2006 |
31/12/2005 |
|
|
|
|
|
|
CASH AND BANKS |
17.139.127,66 |
18.578.594,99 |
15.921.860,84 |
|
CLIENTS |
20.454.395,88 |
19.142.583,73 |
21.513.653,38 |
|
INVENTORY |
7.474.616,29 |
8.438.310,01 |
7.842.926,44 |
|
CHECKS |
51.335,20 |
89.886,83 |
141.578,30 |
|
ADVANCE TO SUPPLIERS |
2.120.749,46 |
243.459,67 |
87.321,41 |
|
ADVANCE TO EMPLOYEES |
246.608,29 |
93.269,70 |
115.084,10 |
|
DEPOSITS & GUARANTEE |
10.535,24 |
10.535,24 |
10.535,24 |
|
RECOVERABLE TAXES |
2.956.639,25 |
1.505.784,04 |
891.466,35 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
50.454.007,27 |
48.102.424,21 |
46.524.426,06 |
|
LONG-TERM
RECEIVABLES: |
|
|
|
|
|
|
|
|
|
JUDICIAL DEPOSITS |
1.044.806,30 |
430.278,44 |
355.284,02 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
1.044.806,30 |
430.278,44 |
355.284,02 |
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
INVESTMENTS |
1.003.074,79 |
1.003.074,79 |
1.003.074,79 |
|
FIXED ASSETS |
18.632.307,20 |
19.525.410,89 |
20.629.376,38 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
19.635.381,99 |
20.528.485,68 |
21.632.451,17 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
71.134.195,56 |
69.061.188,33 |
68.512.161,25 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2007 |
31/12/2006 |
31/12/2005 |
|
|
|
|
|
|
SUPPLIERS |
4.609.794,95 |
4.773.664,42 |
5.569.654,03 |
|
LABOR OBLIGATIONS |
639.459,80 |
687.235,68 |
604.816,32 |
|
TRIBUTARY OBLIGATIONS |
904.547,01 |
1.295.601,79 |
1.531.326,17 |
|
SOCIAL OBLIGATIONS |
371.640,43 |
353.395,36 |
309.827,18 |
|
LOANS AND FINANCING |
296.100,57 |
932.567,82 |
2.281.635,16 |
|
OTHER |
441.445,14 |
182.650,73 |
264.564,75 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
7.262.987,90 |
8.225.115,80 |
10.561.823,61 |
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
11.731.415,26 |
13.378.121,83 |
12.079.994,88 |
|
INSTALLMENTS TAXES PAYABLE |
25.781,93 |
295.564,55 |
601.211,63 |
|
INTERESTS ON OWN CAPITAL |
3.539.285,02 |
1.973.444,12 |
|
|
TAXES AND CONTRIBUTIONS |
4.159.508,41 |
4.615.805,23 |
5.067.822,32 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
19.455.990,62 |
20.262.935,73 |
17.749.028,83 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
4.404.020,00 |
4.404.020,00 |
4.404.020,00 |
|
REVALUATION RESERVES |
8.945.431,42 |
9.830.989,96 |
10.708.434,92 |
|
CAPITAL RESERVES |
800.000,00 |
800.000,00 |
800.000,00 |
|
PROFIT RESERVES |
880.804,00 |
880.804,00 |
880.804,00 |
|
ACCRUED PROFIT (LOSS) |
29.384.961,62 |
24.657.322,84 |
23.408.049,89 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
44.415.217,04 |
40.573.136,80 |
40.201.308,81 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
71.134.195,56 |
69.061.188,33 |
68.512.161,25 |
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2007, 31/12/2006 AND 31/12/2005. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2007 |
31/12/2006 |
31/12/2005 |
|
|
|
|
|
|
GROSS SALES |
86.717.237,39 |
95.846.358,92 |
100.805.941,06 |
|
(-) TAXES ON SALES |
10.528.104,63 |
17.477.279,60 |
18.533.604,79 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
76.189.132,76 |
78.369.079,32 |
82.272.336,27 |
|
(-) COST OF SOLD GOODS |
52.566.792,85 |
53.140.814,78 |
49.638.300,47 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
23.622.339,91 |
25.228.264,54 |
32.634.035,80 |
|
OPERATING REVENUE (EXPENSE) |
-15.813.829,85 |
-19.385.749,71 |
-15.615.213,17 |
|
FINANCIAL REVENUE(EXPENSE) |
-2.797.670,59 |
-3.343.303,12 |
-3.481.237,64 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
5.010.839,47 |
2.499.211,71 |
13.537.584,99 |
|
NON-OPERATING RESULT |
1.145.464,47 |
-688.961,94 |
-82.751,10 |
|
CONTRIBUTION/INCOME TAX |
-2.154.223,70 |
-1.438.421,78 |
-1.934.424,05 |
|
PROFIT SHARING |
-160.000,00 |
|
|
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
3.842.080,24 |
371.827,99 |
11.520.409,84 |
|
RATIOS: |
31/12/2007 |
31/12/2006 |
31/12/2005 |
|
QUICK RATIO |
5,92 |
|
4,82 |
|
3,66 |
|
|
CURRENT RATIO |
6,95 |
|
5,85 |
|
4,41 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
3,72 |
TIMES |
4,09 |
TIMES |
3,82 |
TIMES |
|
DAYS' SALES IN RECEIVABLES |
96,65 |
DAYS |
87,93 |
DAYS |
94,14 |
DAYS |
|
INVENTORY TURNOVER |
7,03 |
TIMES |
6,30 |
TIMES |
6,33 |
TIMES |
|
ACCOUNTS PAYABLE PERIOD |
31,57 |
DAYS |
32,34 |
DAYS |
40,39 |
DAYS |
|
RETURN ON ASSETS |
1,07 |
TIMES |
1,13 |
TIMES |
1,20 |
TIMES |
|
SALES TURNOVER ON NET EQUITY |
1,72 |
TIMES |
1,93 |
TIMES |
2,05 |
TIMES |
|
NET WORTH TIE-UP |
,42 |
|
,48 |
|
,51 |
|
|
INDEBTEDNESS |
,60 |
|
,70 |
|
,70 |
|
|
EQUITY RATIO |
62,44 |
% |
58,75 |
% |
58,68 |
% |
|
WORKING CAPITAL RATIO |
594,67 |
% |
484,82 |
% |
340,50 |
% |
|
GENERAL SOLVENCY |
2,66 |
|
2,42 |
|
2,42 |
|
|
RETURN ON NET EQUITY |
8,65 |
% |
,92 |
% |
28,66 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
5,04 |
% |
,47 |
% |
14,00 |
% |
|
GROSS PROFIT MARGIN |
31,00 |
% |
32,19 |
% |
39,67 |
% |
|
OPERATIONAL RESULT |
6,58 |
% |
3,19 |
% |
16,45 |
% |
|
SALES TURNOVER ON LIABILITIES |
10,49 |
TIMES |
9,53 |
TIMES |
7,79 |
TIMES |
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 1,82 |
- OFFICIAL RATE ON 23/09/2008 |
|
US$ 1,00 = R$ 1,77 |
- OFFICIAL RATE ON 31/12/2007 |
|
US$ 1,00 = R$ 2,13 |
- OFFICIAL RATE ON 31/12/2006 |
|
US$ 1,00 = R$ 2,34 |
- OFFICIAL RATE ON 31/12/2005 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A NORMAL FINANCIAL SITUATION. THE LEVEL OF
INDEBTEDNESS IS LOW AND THE LIQUIDITY INCREASED. IT IS NOTED DOWNWARD SALES TREND
BUT THE PROFITABILITY IMPROVED. TOTAL OF SALES UNTIL AUGUST 2008 : R$ 69.133.400,00. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$ 3.000.000,00
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$ 25.000,00
|
MACHINES: |
NOT AVAILABLE
|
NOT DISCLOSED. |
|
|
BRANCH/PHONE: |
CITY: |
|
BANCO DO BRASIL
S/A |
ALTEROSA |
CONTAGEM/MG |
|
BANCO RURAL S/A |
SANTO AGOSTINHO |
BELO
HORIZONTE/MG |
|
BANCO NOSSA
CAIXA S/A |
AV BRASIL, 1497
- FUNCIONÁRIOS |
BELO HORIZONTE/MG |
|
REMARKS: IN BRAZIL THE BANKS ARE
PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR
CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING
DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL
REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF
"CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). DATE RESEARCHED SEPTEMBER
23, 2008. |
|
THE SUBJECT IS ENGAGED IN THE MANUFACTURE OF PHARMACEUTICAL PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
GERMANY, INDIA, ENGLAND AND SWITZERLAND |
EXPORTS TO:
|
DOES NOT EXPORT. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
CITY: |
PHONE: |
|
BH FARMA COMERCIO E REPRESENTAÇÕES LTDA |
BELO HORIZONTE/MG |
31 3421-9400 |
|
POLAR FIX MATERIAL HOSPITALAR LTDA |
MAUÁ/SP |
11 451-2860 |
|
SECRETARIA MUNICIPAL DE SAÚDE |
RIO DE JANEIRO/RJ |
21 2503-2221 |
|
STAFF: |
|
|
|
THE COMPANY HAS: 465 EMPLOYEE(S) |
|
THE SUBJECT IS A
WELL-ESTABLISHED COMPANY, OPERATING SINCE 1984. SO FAR IT HAS A CLEAR TRADE
HISTORY AND NORMAL PAYMENT BEHAVIOR. THE COMPANY HAS
TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT
FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S
NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
PHONE: |
|
ALLPLAS IND. E COMÉRCIO PLÁSTICOS LTDA |
|
11 4613-1000 |
|
CIV CIA IND. DE VIDROS |
|
11 2172-7433 |
|
GALENA QUÍMICA E FARMACÊUTICA LTDA |
|
0800-144150 |
|
M. CASSAB COMÉRCIO E IND. LTDA |
|
31 3411-2817 |
|
OXITENO NORDESTE S/A INDUSTRIA E COMERCIO |
|
11 3177-6974 |
|
SAINT GOBAIN VIDROS S/A |
|
11 3874-7551 |
|
SCHOTT DO BRASIL LTDA |
|
11 4591-0223 |
|
SHEELMAR EMBALAGEM MODERNA LTDA |
|
31 3287-7566 |
|
PAYMENT HISTORY: |
|
18 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 125.778,00 |
|
|
|
AMOUNT OF INVOICES PAID: 80 |
|
TOTAL OF PROMPT PAYMENTS: 97,8% |
|
TOTAL OF DELAYED PAYMENTS: 2,2% |
|
|
|
HIGHEST INVOICE: R$ 46.386,00 |
|
HIGHEST CREDIT: R$ 46.386,00 |
|
|
|
OUTSTANDING
INVOICES DUE WITHIN THE NEXT 60 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
1 |
2 |
R$ 1.255,00 |
|
DUE WITHIN 60 DAYS |
1 |
1 |
R$ 2.930,00 |
|
ALL |
2 |
3 |
R$ 4.185,00 |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS.
UP TO DATE IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE. BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD
TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN
TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. THE COMPANY HAS PAYMENT CAPACITY AND IS CONSIDERED CREDITWORTHY FOR A
CREDIT LIMIT OF US$ 1.000.000,00. |
|
HIPOLABOR
FARMACEUTICA LTDA. |
|
|
|
BALANCE SHEET
ANALYSIS |
FIGURES ARE IN
REAIS |
|
|
|
31-12-07 |
|
|
ASSETS |
|
% |
|
Current Assets |
70.93 |
|
|
Fixed Assets |
$ 19,635,382 |
27.60 |
|
TOTAL ASSETS |
$ 71,134,196 |
100.00 |
|
LIABILITIES |
|
|
|
Current Liabilities |
$ 7,262,988 |
10.21 |
|
Long-Term Liabilities |
$ 19,455,991 |
27.35 |
|
TOTAL LIABILITIES |
$ 26,718,979 |
37.56 |
|
Deferred Income |
$ -
|
0.00 |
|
Net Equity |
$ 44,415,217 |
62.44 |
|
TOTAL LIABILITIES + NET EQUITY |
$ 71,134,196 |
100.00 |
|
PROFIT AND LOSS ACCOUNTS |
|
|
|
Net Sales |
$ 76,189,133 |
100.00 |
|
Costs |
$ 52,566,793 |
69.00 |
|
Gross Profit |
$ 23,622,340 |
31.00 |
|
Operating expenses |
$
(15,813,830) |
-20.76 |
|
operational Result |
$ 5,010,839 |
6.58 |
|
Net Profit (loss) |
$ 3,842,080 |
5.04 |
|
COMPLEMENTARY DATA |
|
|
|
Inventory |
$ 7,474,616 |
|
|
Accounts receivable |
$ 20,454,396 |
|
|
Accounts Payable |
$ 4,609,795 |
|
|
Property, plant and equipment |
$ 18,632,307 |
|
|
Purchases |
$ 19,635,382 |
|
|
Financial Expenses |
$ (2,797,671) |
|
|
Foreign Currency Assets |
|
|
|
Foreign Currency Liabilities |
|
|
|
Working Capital |
$ 43,191,019 |
|
|
RATIOS: |
|
|
|
QUICK RATIO |
5.92 |
|
|
CURRENT RATIO |
6.95 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
3.72 |
times |
|
DAYS' SALES IN RECEIVABLES |
96.65 |
days |
|
INVENTORY TURNOVER |
7.03 |
times |
|
31.57 |
days |
|
|
RETURN ON ASSETS |
1.07 |
times |
|
SALES TURNOVER ON NET EQUIY |
1.72 |
times |
|
NET WORTH TIE-UP |
0.42 |
|
|
ENDEBTEDNESS |
0.60 |
|
|
EQUITY RATIO |
62.44 |
% |
|
WORKING CAPITAL RATIO |
594.67 |
% |
|
GENERAL SOLVENCY |
2.66 |
|
|
RETURN ON NET EQUITY |
8.65 |
% |
|
RETURN ON SALES (PROFIT
MARGIN) |
5.04 |
% |
|
GROSS PROFIT MARGIN |
31.00 |
% |
|
OPERATIONAL RESULT |
6.58 |
% |
|
SALES TURNOVER ON LIABILITIES |
10.49 |
times |
|
FOREIGN CURRENCY ON ASSETS |
- |
% |
|
FOREIGN CURRENCY ON
LIABILITIES |
- |
% |
|
HIPOLABOR FARMACEUTICA
LTDA. |
|
|
|
|
|
BALANCE SHEET
ANALYSIS |
|
|
|
|
|
|
31-12-06 |
|
31-12-05 |
|
|
ASSETS |
|
% |
|
% |
|
Current Assets |
$ 48,102,424 |
69.65 |
$ 46,524,426 |
67.91 |
|
Fixed Assets |
$ 20,528,486 |
29.73 |
$ 21,632,451 |
31.57 |
|
TOTAL ASSETS |
$ 69,061,188 |
100.00 |
$ 68,512,161 |
100.00 |
|
LIABILITIES |
|
|
|
|
|
Current Liabilities |
$ 8,225,116 |
11.91 |
$ 10,561,824 |
15.42 |
|
Long-Term Liabilities |
$ 20,262,936 |
29.34 |
$ 17,749,029 |
25.91 |
|
TOTAL LIABILITIES |
$ 28,488,052 |
41.25 |
$ 28,310,852 |
41.32 |
|
Deferred Income |
$ - |
0.00 |
$ - |
0.00 |
|
Net Equity |
$ 40,573,137 |
58.75 |
$ 40,201,309 |
58.68 |
|
TOTAL LIABILITIES + NET EQUITY |
$ 69,061,188 |
100.00 |
$ 68,512,161 |
100.00 |
|
PROFIT AND LOSS ACCOUNTS |
|
|
|
|
|
Net Sales |
$ 78,369,079 |
100.00 |
$ 82,272,336 |
100.00 |
|
Costs |
$ 53,140,815 |
67.81 |
$ 49,638,300 |
60.33 |
|
Gross Profit |
$ 25,228,265 |
32.19 |
$ 32,634,036 |
39.67 |
|
Operating expenses |
$ (19,385,750) |
-24.74 |
$ (15,615,213) |
-18.98 |
|
operational Result |
$ 2,499,212 |
3.19 |
$ 13,537,585 |
16.45 |
|
Net Profit (loss) |
$ 371,828 |
0.47 |
$ 11,520,410 |
14.00 |
|
COMPLEMENTARY DATA |
|
|
|
|
|
Inventory |
$ 8,438,310 |
|
$ 7,842,926 |
|
|
Accounts receivable |
$ 19,142,584 |
|
$ 21,513,653 |
|
|
Accounts Payable |
$ 4,773,664 |
|
$ 5,569,654 |
|
|
Property, plant and equipment |
$ 19,525,411 |
|
$ 20,629,376 |
|
|
Purchases |
$ 20,528,486 |
|
$ 21,632,451 |
|
|
Financial Expenses |
$ (3,343,303) |
|
$ (3,481,238) |
|
|
Foreign Currency Assets |
|
|
|
|
|
Foreign Currency Liabilities |
|
|
|
|
|
Working Capital |
$ 39,877,308 |
|
$ 35,962,602 |
|
|
RATIOS: |
|
|
|
|
|
QUICK RATIO |
4.82 |
|
3.66 |
|
|
CURRENT RATIO |
5.85 |
|
4.40 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
4.09 |
times |
3.82 |
times |
|
DAYS' SALES IN RECEIVABLES |
87.93 |
days |
94.14 |
days |
|
INVENTORY TURNOVER |
6.30 |
times |
6.33 |
times |
|
ACCOUNTS PAYABLE PERIOD |
32.34 |
days |
40.39 |
days |
|
RETURN ON ASSETS |
1.13 |
times |
1.20 |
times |
|
SALES TURNOVER ON NET EQUIY |
1.93 |
times |
2.05 |
times |
|
NET WORTH TIE-UP |
0.48 |
|
0.51 |
|
|
ENDEBTEDNESS |
0.70 |
|
0.70 |
|
|
EQUITY RATIO |
58.75 |
% |
58.68 |
% |
|
WORKING CAPITAL RATIO |
484.82 |
% |
340.50 |
% |
|
GENERAL SOLVENCY |
2.42 |
|
2.42 |
|
|
RETURN ON NET EQUITY |
0.92 |
% |
28.66 |
% |
|
RETURN ON SALES (PROFIT
MARGIN) |
0.47 |
% |
14.00 |
% |
|
GROSS PROFIT MARGIN |
32.19 |
% |
39.67 |
% |
|
OPERATIONAL RESULT |
3.19 |
% |
16.45 |
% |
|
SALES TURNOVER ON LIABILITIES |
9.53 |
times |
7.79 |
times |
|
FOREIGN CURRENCY ON ASSETS |
- |
% |
- |
% |
|
FOREIGN CURRENCY ON
LIABILITIES |
- |
% |
- |
% |

FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.43 |
|
UK Pound |
1 |
Rs.85.38 |
|
Euro |
1 |
Rs.67.95 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)